ERBB2 and breast carcinoma: Specific post-translational modifications of MZF1 are induced in invasive cancer, as is the case for breast cancer harboring ErbB2 activation, and these are necessary for the invasive signaling mediated via MZF1 in response to ErbB2 activation in breast cancer cells [22].